Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)
Condition(s):Systemic Lupus ErythematosusLast Updated:September 14, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Systemic Lupus ErythematosusLast Updated:September 14, 2023Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:March 25, 2024Recruiting
Condition(s):Vasculitis LupusLast Updated:December 14, 2020Unknown status
Condition(s):Systemic Lupus Erythematosus (SLE)Last Updated:April 6, 2023Recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:March 26, 2024Recruiting
Condition(s):Systemic Lupus Erythematosus (SLE)Last Updated:February 28, 2024Recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:November 18, 2023Not yet recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:April 28, 2023Not yet recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:March 26, 2024Recruiting
Condition(s):Elevated Level of IFN Type I in SLE PatientsLast Updated:July 6, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.